These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 26650112)

  • 1. Voriconazole Concentrations in Cerebrospinal Fluid During Prophylactic Use in Children with Acute Myelogenous Leukemia.
    Kobayashi R; Sano H; Kishimoto K; Suzuki D; Yasuda K; Kobayashi K
    Pediatr Infect Dis J; 2016 Mar; 35(3):297-8. PubMed ID: 26650112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic administration of voriconazole with two different doses for invasive fungal infection in children and adolescents with acute myeloid leukemia.
    Sano H; Kobayashi R; Hori D; Kishimoto K; Suzuki D; Yasuda K; Kobayashi K
    J Microbiol Immunol Infect; 2018 Apr; 51(2):260-266. PubMed ID: 27329132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective CYP2C19-Guided Voriconazole Prophylaxis in Patients With Neutropenic Acute Myeloid Leukemia Reduces the Incidence of Subtherapeutic Antifungal Plasma Concentrations.
    Hicks JK; Quilitz RE; Komrokji RS; Kubal TE; Lancet JE; Pasikhova Y; Qin D; So W; Caceres G; Kelly K; Salchert YS; Shahbazian K; Abbas-Aghababazadeh F; Fridley BL; Velez AP; McLeod HL; Greene JN
    Clin Pharmacol Ther; 2020 Mar; 107(3):563-570. PubMed ID: 31549389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Voriconazole as primary antifungal prophylaxis in patients with neutropenia after hematopoietic stem cell transplantation or chemotherapy for acute myeloid leukemia.
    Torres A; Serrano J; Rojas R; Martín V; Martín C; Tabares S; Molina JR; Capote M; Martínez F; Gómez P; Sánchez-García J
    Eur J Haematol; 2010 Mar; 84(3):271-3. PubMed ID: 19878274
    [No Abstract]   [Full Text] [Related]  

  • 5. Voriconazole Dosing in Children Younger Than 3 Years Undergoing Cancer Chemotherapy or Hematopoietic Stem Cell Transplantation.
    Yan SQ; Seyboth B; Kobos R; Eaton A; Seo SK; Cohen N
    J Pediatric Infect Dis Soc; 2018 May; 7(2):169-171. PubMed ID: 28407118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral voriconazole versus intravenous low dose amphotericin B for primary antifungal prophylaxis in pediatric acute leukemia induction: a prospective, randomized, clinical study.
    Mandhaniya S; Swaroop C; Thulkar S; Vishnubhatla S; Kabra SK; Xess I; Bakhshi S
    J Pediatr Hematol Oncol; 2011 Dec; 33(8):e333-41. PubMed ID: 22042283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment with voriconazole for invasive fungal infection during chemotherapy for leukemia: doses and plasma concentration of voriconazole in children].
    Fukushima K; Fujisawa M; Nakajima D; Matsunaga T; Hagisawa S; Kurosawa H; Sugita K; Arisaka O
    Rinsho Ketsueki; 2007 May; 48(5):402-6. PubMed ID: 17571586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The incidence of invasive fungal infections in neutropenic patients with acute leukemia and myelodysplastic syndromes receiving primary antifungal prophylaxis with voriconazole.
    Barreto JN; Beach CL; Wolf RC; Merten JA; Tosh PK; Wilson JW; Hogan WJ; Litzow MR
    Am J Hematol; 2013 Apr; 88(4):283-8. PubMed ID: 23460251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Voriconazole prophylaxis in children with cancer: changing outcomes and epidemiology of fungal infections.
    Maron GM; Hayden RT; Rodriguez A; Rubnitz JE; Flynn PM; Shenep JL; Knapp KM
    Pediatr Infect Dis J; 2013 Dec; 32(12):e451-5. PubMed ID: 23907262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of oral voriconazole during chemotherapy for acute myeloid leukemia and myelodysplastic syndrome: a Japanese nationwide retrospective cohort study.
    Tsutsumi I; Kunisawa S; Yoshida C; Seki M; Komeno T; Fushimi K; Morita S; Imanaka Y
    Int J Clin Oncol; 2019 Nov; 24(11):1449-1458. PubMed ID: 31300904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No difference between posaconazole and fluconazole antifungal prophylaxis and mycological diagnostics except costs in patients undergoing AML chemotherapy: a 1-year "real-life" evaluation.
    Bertz H; Drognitz K; Lübbert M
    Ann Hematol; 2014 Jan; 93(1):165-7. PubMed ID: 23949313
    [No Abstract]   [Full Text] [Related]  

  • 12. A double-blind trial on prophylactic voriconazole (VRC) or placebo during induction chemotherapy for acute myelogenous leukaemia (AML).
    Vehreschild JJ; Böhme A; Buchheidt D; Arenz D; Harnischmacher U; Heussel CP; Ullmann AJ; Mousset S; Hummel M; Frommolt P; Wassmer G; Drzisga I; Cornely OA
    J Infect; 2007 Nov; 55(5):445-9. PubMed ID: 17822770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infantile Aspergillus fumigatus ventriculitis successfully treated with monitoring of plasma and cerebrospinal fluid voriconazole concentration level.
    Furudate A; Hirose S; Abe K; Kawashima A; Hashimoto K; Yamazaki S; Kamei K; Ishiwada N; Hamada H; Sato M
    J Infect Chemother; 2020 Jan; 26(1):132-135. PubMed ID: 31350185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe infections in children with acute leukemia undergoing intensive chemotherapy can successfully be prevented by ciprofloxacin, voriconazole, or micafungin prophylaxis.
    Yeh TC; Liu HC; Hou JY; Chen KH; Huang TH; Chang CY; Liang DC
    Cancer; 2014 Apr; 120(8):1255-62. PubMed ID: 24415457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetics of posaconazole in neutropenic patients receiving chemotherapy for acute myelogenous leukemia or myelodysplastic syndrome.
    AbuTarif MA; Krishna G; Statkevich P
    Curr Med Res Opin; 2010 Feb; 26(2):397-405. PubMed ID: 20001450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacoeconomic evaluation of fluconazole, posaconazole and voriconazole for antifungal prophylaxis in patients with acute myeloid leukaemia undergoing first consolidation chemotherapy.
    Heng SC; Slavin MA; Al-Badriyeh D; Kirsa S; Seymour JF; Grigg A; Thursky K; Bajel A; Nation RL; Kong DC
    J Antimicrob Chemother; 2013 Jul; 68(7):1669-78. PubMed ID: 23485723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Need of voriconazole high dosages, with documented cerebrospinal fluid penetration, for treatment of cerebral aspergillosis in a 6-month-old leukaemic girl.
    Palmisani E; Barco S; Cangemi G; Moroni C; Dufour C; Castagnola E
    J Chemother; 2017 Feb; 29(1):42-44. PubMed ID: 25748533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Voriconazole serum concentrations in prophylactically treated acute myelogenous leukaemia patients.
    Rüping MJ; Müller C; Vehreschild JJ; Böhme A; Mousset S; Harnischmacher U; Frommolt P; Wassmer G; Drzisga I; Hallek M; Cornely OA
    Mycoses; 2011 May; 54(3):230-3. PubMed ID: 19889174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of C-reactive protein levels on voriconazole metabolism at three age groups in allogeneic hematopoietic cell transplant recipients.
    Luo X; Li T; Hu L; Liu S; Zhao H; Zhang J; Feng Y; Huang L
    J Chemother; 2021 Apr; 33(2):95-105. PubMed ID: 32441568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and distribution of voriconazole in body fluids of dogs after repeated oral dosing.
    Lemetayer JD; Dowling PM; Taylor SM; Papich MG
    J Vet Pharmacol Ther; 2015 Oct; 38(5):451-6. PubMed ID: 25691353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.